ETIDIOH - NEW

  By Eric.Coffinet~commonswiki assumed (based on copyright claims). - No machine-readable source provided. Own work assumed (based on copyright claims)., Public Domain,  https://commons.wikimedia.org/w/index.php?curid=10366620 Source:  Link:  https://commons.wikimedia.org/wiki/Category:Brissonneau_et_Lotz_locomotives ____

  Clin Infect Dis LIANG C, Judy J, Chilson EL, Kelly SP, et al Estimating Risk of Guillain-Barre Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-Controlled Case Series Analysis. Clin Infect Dis. 2025 Nov 14:ciaf621. doi: 10.1093. PubMed           Abstract available ZUGER A Home testing for contagious illness: Historical context and modern caveats. Clin Infect Dis. 2025 Nov 14:ciaf623. doi: 10.1093. PubMed           Abstract available Int J Infect Dis AHMAD WA, Wolff-Sagy Y, Battat E, Arbel R, et al Mortality following recovery from COVID-19 hospitalization: a long-term cohort study. Int J Infect Dis. 2025 Nov 13:108223. doi: 10.1016/j.ijid.2025.108223. PubMed           Abstract available WANG C, Gao Y, Li W, Du J, et al Short-Term Risks of Influenza and COVID-19 Following Influenza Infection: A...

  Ann Intern Med QASEEM A, Wilt TJ, Harrod CS, Obley AJ, et al Influenza Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians. Ann Intern Med. 2025 Nov 18. doi: 10.7326/ANNALS-25-04056. PubMed           Abstract available Web Exclusive. Annals Video Summary - Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Ann Intern Med. 2025 Nov 18:e2504658VS. doi: 10.7326/ANNALS-25-04658. PubMed          DOBRESCU AI, Sharifan A, Sommer I, Neubauer-Bruckner CIA, et al Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians. Ann Intern Med. 2025 Nov 18. doi: 10.7326/ANNALS-25-04028. PubMed   ...

  {Summary} SARS-CoV-2 continues to evolve, with successive variants evading immunity established by previous infection or vaccination . In mid-2024, a vaccine tailored to the JN.1 variant was authorised by the European Medicines Agency (EMA), which boosted neutralising antibody responses and provided substantial protection against severe disease and hospitalisation.1–3 Around 6 months later, in January 2025, LP.8.1 (of the JN.1 lineage) was classified as a “ variant under monitoring ” by WHO, due to its epidemiological importance and enhanced transmission fitness relative to contemporaneous strains. After emerging in late 2024, LP.8.1 rapidly overtook the XEC variant, establishing dominance throughout the Americas and Europe by early 2025 . In the USA, LP.8.1 and its sublineages represented more than 50% of all sequences in May, 2025 (appendix p 9). Although vaccines adapted to JN.1 or its derivative KP.2 generated neutralising antibodies against LP.8.1, these titres were reduced ...

  The person was infected with the H5N5 virus; the risk to the public remains low OLYMPIA – A Grays Harbor County resident who was undergoing treatment for H5N5 avian influenza died today .  The Washington State Department of Health offers its heartfelt condolences to the person’s family and friends. The person was an older adult with underlying health conditions .  Out of respect for the family’s privacy , we are not releasing their name, gender, or age.  The person had been hospitalized in King County since early November. Testing at the UW Medicine Clinical Virology Lab identified the virus as H5N5 , making this the first recorded infection with this variant in a person globally.  The result was confirmed by the Centers for Disease Control and Prevention (CDC). The risk to the public remains low .  No other people involved have tested positive for avian influenza.  Public health officials will continue to monitor anyone who was in close contact with...